..............page:1223-1226
..............page:1227-1229
..............page:1230-1232
..............page:1233-1235
..............page:1236-1238
..............page:1239-1241
..............page:1242-1245
..............page:1246-1248
..............page:1249-1251+1261
..............page:1252-1254
..............page:1255-1257
..............page:1258-1261
..............page:1262-1264
Research on degradation of dural sealant material in vivo
YU Pei;YANG Xi;ZHANG Jing-jing;JIAO Jian-jie;LI Qin;LI Jing;YIN YU-qing;AN Meng-yao;LAO Jian-shi;Department of Pharmacology;Basic Medical College;Tianjin Medical University;Department of Pharmacy;Tianjin Third Central Hospital;Beijing Sage Technology Co.LTD;
..............page:1265-1267
..............page:1268-1270
Effects of temozolomide easter on glioma cells and its possible mechanisms
GUO Shan-shan;ZHU Zhong-ling;XU Hui;DING Feng-xia;WANG Guo-cheng;ZHAO Min;YAN Zhao;Department of Clinical Pharmacology;National Clinical Research Center for Cancer;Key Laboratory of Cancer Prevention and Therapy;Tianjin Medical University Cancer Institute and Hospital;Tasly R&D Institute;Tianjin Tasly Group Co.;
..............page:1271-1275
..............page:1276-1278
..............page:1279-1282
..............page:1283-1285
..............page:1286-1288
..............page:1289-1291
..............page:1292-1295
..............page:1296-1298
..............page:1299-1301
Therapeutic drug monitoring for peripartum use of imipenem/cilastatin
LIU Wei;ZHU Li-qin;ZHANG Xian-hua;WEI Yuan;XIONG Xin;LIU Yang;YANG Li;Department of Pharmacy;Peking University Third Hospital;Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University;Peking University Third Hospital;Department of Pharmacy;Tianjin First Center Hospital;Department of Gynaecology and Obstetrics;Peking University Third Hospital;
..............page:1302-1303+1306
..............page:1304-1306
..............page:1307-1308+1311
..............page:1309-1311
..............page:1312-1314
..............page:1315-1317
..............page:1318-1320
..............page:1321-1324
..............page:1325-1327
..............page:1328-1330
Research progress of contrast-induced nephropathy
An Shuo-yan;FAN Chao-mei;LI Yi-shi;Key Laboratory of Clinical Trial Research in Cardiovascular Drugs;Ministry of Health;State Key Laboratory of Cardiovascular Disease;Fuwai Hospital;National Center for Cardiovascular Disease;Chinese Academy of Medical Sciences and Peking Union Medical College;
..............page:1331-1334
..............page:1335-1337
..............page:1338-1340
..............page:1341-1343
..............page:1344-1347
..............page:1348-1352
..............page:1353-1357
..............page:1358-1360